Negative regulation of astrocyte activation

pathway activity — cross-omics
GO:0061889Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of astrocyte activation pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are RIPK3, HAVCR2, and AIF1, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of astrocyte activation activity versus RIPK3 in BRCA (Pearson r = 0.42).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCARIPK3 →+1.549+0.192<.001.00623
GBMHAVCR2 →+1.032+0.844<.001<.00132
GBMAIF1 →+0.917+0.792.003<.00132
LSCCVAT1 →+0.836+0.235.001<.00132
LSCCDUSP3 →+0.452+0.176.002.00332
LSCCRGS19 →+0.520+0.141.004.00432
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0061889 vs RIPK3 — BRCA

Per-sample scatter of Negative regulation of astrocyte activation activity vs RIPK3 in BRCA.

Explore this scatter interactively →

Exploration